← back to search

Gregor Paul

Augsburg University · US
Area of research
Infectious Diseases · Neurology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, and Inflammatory Bowel Disease.
h-index
12
citations
856
works
49
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
The Lancet Infectious Diseases 2024cited by 76position: middledoi
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
Journal of Clinical Investigation 2022cited by 22position: middledoi
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Frontiers in Immunology 2022cited by 6position: middledoi
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Clinical Microbiology and Infection 2021cited by 228position: middledoi
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19
Journal of Clinical Investigation 2021cited by 89position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bernd Jahrsdörfer · University Hospital Ulm1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Eva Schrezenmeier · Leibniz Association1 papers (2022–2022)Héctor Rincón-Arévalo · Leibniz Association1 papers (2022–2022)Daniel Zickler · St. Joseph-Krankenhaus1 papers (2022–2022)Hinnerk Wulf · Philipps University of Marburg1 papers (2022–2022) · 1 papers (2022–2022)Hubert Schrezenmeier · Heinrich Heine University Düsseldorf1 papers (2022–2022)Lucas Ernst · Statistics Austria1 papers (2022–2022)Sebastian Zinn · Columbia University Irving Medical Center1 papers (2022–2022) · 1 papers (2022–2022)Thomas Dörner · Leibniz Association1 papers (2022–2022)Erhard Seifried · German Red Cross1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Daniel Fürst · German Red Cross1 papers (2022–2022)Martin Bentz · Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie1 papers (2022–2022) · 1 papers (2022–2022)